샘플 요청 목록

 카트 문의
시장보고서
상품코드
1564069

세계의 심폐 자동 수혈 시스템 시장

Cardiopulmonary Autotransfusion Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심폐 자동 수혈 시스템 세계 시장은 2030년까지 7억 5,960만 달러에 달할 것으로 전망

2023년 6억 5,380만 달러로 추정되는 심폐 자동 수혈 시스템 세계 시장은 2030년에는 7억 5,960만 달러에 달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 2.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 온펌프 수혈 장치 부문은 CAGR 2.4%를 기록하여 분석 기간이 끝날 때까지 5억 2,380만 달러에 도달할 것으로 예상됩니다. 오프펌프 수혈 장치 부문은 분석 기간 동안 CAGR 1.7%의 성장률을 나타낼 것으로 추정됩니다.

미국 시장은 1억 7,590만 달러로 추정, 중국은 CAGR 1.7%로 성장 전망

미국의 심폐 자동 수혈 시스템 시장은 2023년 1억 7,590만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년의 분석 기간 동안 1.7%의 연평균 복합 성장률(CAGR)로 2030년까지 1억 1,800만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 분석 기간 동안 각각 2.2%와 1.4%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 1.6%의 성장률을 보일 것으로 예상됩니다.

세계 심폐 자동 수혈 시스템 시장 - 주요 동향 및 촉진요인 요약

심폐 자동 수혈 시스템은 외과 수술의 혈액 관리에 어떤 혁명을 가져오고 있는가?

심폐 자동 수혈 시스템은 수술 중 환자가 자신의 혈액을 회수하여 재사용할 수 있도록 함으로써 현대 수술에서 중요한 역할을 하고 있습니다. 이러한 시스템은 특히 심장 수술이나 외상 수술과 같이 많은 양의 혈액을 잃는 수술에 필수적입니다. 전통적으로 수혈은 기증자의 혈액에 의존해 왔지만, 이 방법은 감염, 면역 반응, 혈액 부족 등의 위험을 수반합니다. 자가 수혈 시스템은 수술 중 환자 자신의 혈액을 채취, 여과 및 재수혈하여 이러한 문제를 줄입니다. 이는 기증자 혈액의 필요성을 감소시킬 뿐만 아니라 수혈 반응과 관련된 위험도 감소시킵니다. 또한 이러한 시스템은 환자가 더 신선하고 호환성이 높은 혈액을 받고 회복 시간을 개선하고 수술 후 합병증의 가능성을 줄입니다. 출혈량을 효율적으로 관리하는 것이 가장 중요한 심폐 수술에서 자동 수혈 시스템은 환자의 안정을 유지하고 의료 시스템에서 기증자 혈액에 대한 전반적인 수요를 줄이는 데 필수적입니다.

기술은 어떻게 심폐 자동 수혈 시스템을 향상시켰습니까?

기술의 발전으로 심폐 자동 수혈 시스템의 효율성과 신뢰성이 크게 향상되어 수술 중 출혈을 효과적으로 관리할 수 있게 되었습니다. 최신 자동 수혈 장비는 고급 여과 및 분리 기술을 통해 더 높은 품질의 재수혈을 보장합니다. 이 시스템은 적혈구를 지방, 뼈 조각, 혈전과 같은 오염 물질로부터 효과적으로 분리하여 여과된 깨끗한 혈액만 환자에게 다시 공급할 수 있습니다. 또한, 새로운 시스템은 더욱 컴팩트하고 사용하기 쉬워졌으며, 설치가 빠르고 수술 워크플로우에 쉽게 통합할 수 있습니다. 이 장비의 휴대성은 대형 고정식 장비 없이도 주요 심장 수술부터 외상 센터에 이르기까지 다양한 환경에서 사용할 수 있다는 것을 의미합니다. 또한, 자동 처리 시스템의 도입으로 수작업이 줄어들어 인적 오류의 가능성을 최소화하고 자동 수혈 과정의 안전성과 신뢰성을 향상시켰습니다. 대부분의 최신 시스템은 실시간 모니터링 및 데이터 수집 기능을 갖추고 있어 수술팀이 수술 내내 혈액량과 혈액의 질을 추적할 수 있어 환자의 결과를 최적화할 수 있도록 돕습니다. 이러한 기술 혁신은 복잡한 수술 중 안전하고 효율적인 혈액 관리를 제공하는 자동 수혈 시스템의 능력을 크게 향상시키고 있습니다.

심폐 자동 수혈 시스템 시장을 형성하고 있는 동향은?

몇 가지 주요 트렌드가 심폐 자동 수혈 시스템 시장의 성장과 개척에 영향을 미치고 있으며, 이는 의료 관행과 수술 기술의 광범위한 변화를 반영하고 있습니다. 주요 트렌드 중 하나는 환자의 안전과 동종 수혈과 관련된 합병증 감소에 대한 중요성이 점점 더 강조되고 있다는 점입니다. 감염 및 면역 반응과 같은 수혈과 관련된 위험에 대한 인식이 높아짐에 따라 더 안전한 대안으로 자동 수혈 시스템을 채택하는 의료 서비스 제공업체가 증가하고 있습니다. 또한, 기증자 혈액공급 부족과 혈액 보존 및 수혈과 관련된 높은 비용으로 인해 수술 환경에서 혈액 보존 기술에 대한 수요가 증가하고 있습니다. 최소침습 수술로의 전환도 시장에 영향을 미치고 있습니다. 이러한 수술은 덜 침습적이지만 출혈의 위험이 있기 때문에 여전히 효율적인 혈액 관리 시스템이 필요하기 때문입니다. 이러한 추세는 다양한 수술 환경에 적응할 수 있는 더 작고 휴대 가능한 자동 수혈 장치의 개발로 이어지고 있습니다. 또한, 전 세계 의료 시스템이 의료비 절감에 대한 중요성을 점점 더 강조하는 가운데, 자동 수혈 시스템은 비용 효율적인 솔루션으로 각광받고 있습니다. 이러한 시스템은 고가의 기증자 혈액의 필요성을 줄이고 수술 후 합병증을 최소화함으로써 병원이 자원을 보다 효율적으로 관리하면서 환자의 예후를 개선하는 데 도움이 될 수 있습니다.

심폐 자동 수혈 시스템 시장의 성장을 가속하는 주요 요인은?

심폐 자동 수혈 시스템 시장의 성장은 기술 발전, 환자 안전에 대한 인식 증가, 효율적인 혈액 관리 솔루션에 대한 수요 증가가 복합적으로 작용하여 이루어지고 있습니다. 주요 촉진요인 중 하나는 감염, 알레르기 반응, 면역 억제와 같은 위험을 수반할 수 있는 동종 수혈의 안전성에 대한 우려가 증가하고 있다는 점입니다. 의료 서비스 제공업체가 환자의 안전을 우선시함에 따라 이러한 위험을 최소화할 수 있는 안전한 대안을 제공하는 자동 수혈 시스템의 채택이 증가하고 있습니다. 또 다른 중요한 원동력은 특히 혈액 공급 인프라가 제한적인 지역에서는 혈액 공여자의 혈액 비용 상승과 부족입니다. 자가 수혈 시스템은 환자 자신의 혈액을 재사용함으로써 비용 효율적인 솔루션을 제공하여 기증자 혈액에 대한 의존도를 낮추고 전반적인 의료 비용을 절감할 수 있습니다. 기술 발전도 시장 확대에 큰 역할을 하고 있습니다. 최신 자가혈 수혈 시스템은 보다 효율적이고 사용하기 쉬우며 더 나은 품질의 재수혈이 가능하기 때문에 복잡한 수술, 특히 심장, 정형외과 및 외상 수술에 선호되고 있습니다. 최소 침습 수술의 인기가 높아지면서 다양한 수술 환경에 원활하게 통합할 수 있는 소형의 휴대용 자동 수혈 시스템에 대한 수요가 더욱 증가하고 있습니다. 또한 의료 서비스 제공업체는 자원 관리를 개선하기 위해 혈액 보존 전략에 점점 더 중점을두고 있으며 자동 수혈 시스템은 이와 관련하여 효과적인 도구로 간주됩니다. 또한, 규제 기관과 의료 기관은 자동 수혈을 포함한 혈액 관리 프로토콜을 장려하고 있으며, 이는 병원과 수술센터 전체에서 이러한 시스템의 채택을 더욱 촉진하고 있습니다. 이러한 복합적인 요인들이 향후 몇 년동안 심폐 자동 수혈 시스템 시장의 성장을 가속할 것으로 예상됩니다.

조사 대상 기업 예시(주목할 만한 12개 기업)

  • Atrium Medical Corporation
  • Fresenius SE & Co. KGaA
  • Global Blood Resources, LLC
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Redax SpA
  • Stryker Corporation
  • Terumo Medical Corporation -Terumo Interventional Systems

    목차

    제1장 조사 방법

    제2장 주요 요약

    • 시장 개요
    • 주요 기업
    • 시장 동향과 촉진요인
    • 세계 시장 전망

    제3장 시장 분석

    • 미국
    • 캐나다
    • 일본
    • 중국
    • 유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 기타 유럽
    • 아시아태평양
    • 기타 지역

    제4장 경쟁

    LSH 24.10.04

    Global Cardiopulmonary Autotransfusion Systems Market to Reach US$759.6 Million by 2030

    The global market for Cardiopulmonary Autotransfusion Systems estimated at US$653.8 Million in the year 2023, is expected to reach US$759.6 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end of the analysis period. Growth in the Off-Pump Transfusion Device segment is estimated at 1.7% CAGR over the analysis period.

    The U.S. Market is Estimated at US$175.9 Million While China is Forecast to Grow at 1.7% CAGR

    The Cardiopulmonary Autotransfusion Systems market in the U.S. is estimated at US$175.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$118.0 Million by the year 2030 trailing a CAGR of 1.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 1.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

    Global Cardiopulmonary Autotransfusion Systems Market - Key Trends and Drivers Summarized

    How Are Cardiopulmonary Autotransfusion Systems Revolutionizing Blood Management in Surgery?

    Cardiopulmonary autotransfusion systems play a crucial role in modern surgical procedures by allowing patients to recover and reuse their own blood during surgery. These systems are particularly essential in cardiac and trauma surgeries, where significant blood loss is common. Traditionally, blood transfusions have relied on donor blood, but this approach carries risks such as infections, immune reactions, and blood shortages. Autotransfusion systems mitigate these issues by collecting, filtering, and reinfusing the patient’s own blood during the surgical procedure. This not only reduces the need for donor blood but also decreases the risks associated with transfusion reactions. Additionally, these systems ensure that patients receive fresher and more compatible blood, improving recovery times and reducing the likelihood of postoperative complications. In the context of cardiopulmonary surgeries, where managing blood loss efficiently is paramount, autotransfusion systems have become indispensable in maintaining patient stability and reducing the overall demand for donor blood in the healthcare system.

    How Has Technology Improved Cardiopulmonary Autotransfusion Systems?

    Technological advancements have significantly enhanced the efficiency and reliability of cardiopulmonary autotransfusion systems, making them more effective in managing intraoperative blood loss. Modern autotransfusion devices are now equipped with advanced filtration and separation technologies that ensure higher-quality blood reinfusion. These systems can effectively separate red blood cells from contaminants like fat, bone fragments, and clots, ensuring that only clean, filtered blood is returned to the patient. Additionally, newer systems are more compact and user-friendly, allowing for faster setup and easier integration into surgical workflows. The portability of these devices means they can be used in a variety of settings, from major cardiac surgeries to trauma centers, without the need for large, stationary machines. Furthermore, the introduction of automated processing systems has reduced the manual intervention required, minimizing the chance of human error and improving the safety and reliability of the autotransfusion process. Many of the latest systems also feature real-time monitoring and data collection capabilities, which allow surgical teams to track blood volume and quality throughout the procedure, ensuring optimal patient outcomes. These technological innovations have greatly improved the ability of autotransfusion systems to provide safe, efficient blood management during complex surgeries.

    What Trends Are Shaping the Cardiopulmonary Autotransfusion Systems Market?

    Several key trends are influencing the growth and development of the cardiopulmonary autotransfusion systems market, reflecting broader shifts in healthcare practices and surgical technologies. One major trend is the increasing emphasis on patient safety and the reduction of complications related to allogeneic blood transfusions. As awareness of the risks associated with donor blood transfusions, such as infections and immune reactions, grows, more healthcare providers are adopting autotransfusion systems as a safer alternative. Additionally, there is a rising demand for blood conservation techniques in surgical settings, driven by shortages in donor blood supplies and the high costs associated with blood storage and transfusion. The shift towards minimally invasive surgeries is also impacting the market, as these procedures, although less invasive, still require efficient blood management systems due to the risk of bleeding. This trend has led to the development of smaller, more portable autotransfusion devices that are adaptable to a range of surgical environments. Moreover, as healthcare systems worldwide place increasing importance on reducing healthcare costs, autotransfusion systems are gaining traction as a cost-effective solution. By reducing the need for expensive donor blood and minimizing postoperative complications, these systems help hospitals manage resources more efficiently while improving patient outcomes.

    What Are the Major Factors Driving Growth of the Cardiopulmonary Autotransfusion Systems Market?

    The growth in the cardiopulmonary autotransfusion systems market is driven by a combination of technological advancements, increased awareness of patient safety, and the rising demand for efficient blood management solutions. One of the primary drivers is the growing concern over the safety of allogeneic blood transfusions, which can carry risks such as infections, allergic reactions, and immune suppression. As healthcare providers prioritize patient safety, the adoption of autotransfusion systems is increasing, offering a safer alternative that minimizes these risks. Another significant driver is the rising cost and shortage of donor blood, particularly in regions with limited blood supply infrastructure. Autotransfusion systems provide a cost-effective solution by recycling the patient’s own blood, reducing the dependency on donor blood and lowering overall healthcare costs. Advancements in technology have also played a major role in expanding the market. Modern autotransfusion systems are more efficient, user-friendly, and capable of delivering higher-quality blood reinfusion, making them a preferred choice in complex surgeries, especially in cardiac, orthopedic, and trauma cases. The growing popularity of minimally invasive surgeries has further increased the demand for compact, portable autotransfusion systems that can be seamlessly integrated into different surgical environments. Additionally, healthcare providers are increasingly focused on blood conservation strategies to improve resource management, and autotransfusion systems are seen as an effective tool in this regard. Moreover, regulatory bodies and healthcare organizations are promoting blood management protocols that include autotransfusion, further driving the adoption of these systems across hospitals and surgical centers. These combined factors are expected to continue fueling the growth of the cardiopulmonary autotransfusion systems market in the coming years.

    Select Competitors (Total 12 Featured) -

    • Atrium Medical Corporation
    • Fresenius SE & Co. KGaA
    • Global Blood Resources, LLC
    • Haemonetics Corporation
    • LivaNova PLC
    • Medtronic PLC
    • Redax SpA
    • Stryker Corporation
    • Terumo Medical Corporation -Terumo Interventional Systems

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    • 1. MARKET OVERVIEW
      • Influencer Market Insights
      • Global Economic Update
      • Cardiopulmonary Autotransfusion Systems - Global Key Competitors Percentage Market Share in 2024 (E)
      • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 2. FOCUS ON SELECT PLAYERS
    • 3. MARKET TRENDS & DRIVERS
      • Advances in Minimally Invasive Surgery Propel Growth of Cardiopulmonary Autotransfusion Systems
      • Aging Population and Increased Cardiovascular Procedures Spur Demand for Autotransfusion Technologies
      • Rising Concerns over Blood Safety and Infection Risks Strengthen the Business Case for Autotransfusion Systems
      • Increased Adoption of Enhanced Filtration Technologies Drives Penetration of Next-Generation Autotransfusion Systems
      • Focus on Blood Conservation in Surgical Procedures Propels Adoption of Autotransfusion Devices
      • Integration of Advanced Monitoring and AI in Autotransfusion Systems Drives Technological Innovation
      • Growing Popularity of Outpatient and Ambulatory Surgical Centers Expands Opportunities for Portable Autotransfusion Systems
      • Surge in Complex Cardiovascular Surgeries Generates Demand for High-Capacity Autotransfusion Devices
      • Here's How Remote Monitoring Capabilities in Autotransfusion Systems Are Transforming Post-Surgical Care
    • 4. GLOBAL MARKET PERSPECTIVE
      • TABLE 1: World Cardiopulmonary Autotransfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
      • TABLE 2: World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 3: World Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 4: World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
      • TABLE 5: World Recent Past, Current & Future Analysis for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 6: World Historic Review for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 7: World 16-Year Perspective for On-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 8: World Recent Past, Current & Future Analysis for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 9: World Historic Review for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 10: World 16-Year Perspective for Off-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 13: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

    III. MARKET ANALYSIS

    • UNITED STATES
      • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
      • TABLE 17: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 18: USA Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 19: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 21: USA Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 22: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • CANADA
      • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 24: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 25: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 27: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 28: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • JAPAN
      • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
      • TABLE 29: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 30: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 31: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 33: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 34: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • CHINA
      • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
      • TABLE 35: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 36: China Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 37: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 38: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 39: China Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 40: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • EUROPE
      • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
      • TABLE 41: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 42: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 43: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
      • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 45: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 46: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 48: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 49: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • FRANCE
      • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
      • TABLE 50: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 51: France Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 52: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 53: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 54: France Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 55: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • GERMANY
      • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
      • TABLE 56: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 57: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 58: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 60: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 61: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • ITALY
      • TABLE 62: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 63: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 64: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 66: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 67: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • UNITED KINGDOM
      • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
      • TABLE 68: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 69: UK Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 70: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 72: UK Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 73: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • REST OF EUROPE
      • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 75: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 76: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 78: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 79: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • ASIA-PACIFIC
      • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
      • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 81: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 82: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 84: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 85: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • REST OF WORLD
      • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 87: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 88: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
      • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 90: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 91: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

    IV. COMPETITION

    • 샘플 요청 목록
    0 건의 상품을 선택 중
    목록 보기
    전체삭제